Zenith Drugs Limited submitted its Structured Digital Database compliance certificate for the financial year 2026. This confirms adherence to SEBI insider trading monitoring regulations.
Promoters of Zenith Drugs Limited submitted an annual declaration for FY 2025-26 under SEBI Takeover Regulations. The filing confirms that the promoter group and persons acting in concert did not create any encumbrances or pledges on their shareholding during the year. This is a routine regulatory compliance disclosure.